Nxera Pharma Co., Ltd. (TYO:4565)

Nxera Pharma Revenue

Nxera Pharma had revenue of 7.65B JPY in the quarter ending June 30, 2026, a decrease of -9.42%. This brings the company's total for the last twelve months to 33.43B, up 7.12% year-over-year. In the year 2025, Nxera Pharma had annual revenue of 29.62B with 2.71% growth. That makes Nxera Pharma the 16,993rd largest company in the world by revenue and 1,855th in Japan.

• Revenue (ttm): 33.43B
• Revenue Growth: +7.12%
• P/S Ratio: 3.73
• Revenue / Employee: 103.82M
• Employees: 322
• Market Cap: 124.55B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 17.97B 60.7%
• United States of America 4.89B 16.5%
• Switzerland 2.17B 7.3%
• United Kingdom 1.77B 6.0%
• Bermuda 1.41B 4.7%
• Germany 1.34B 4.5%
• Others 74.00M 0.2%

Fiscal year ended Dec 31, 2025 See the full Nxera Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	29.62B	780.00M	2.71%
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error